Company intelligence / Profile preview

MiRus

Atlanta, Georgia, United Statesmirusmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

MiRus develops proprietary rhenium-based alloy implants and procedural solutions for orthopedic and cardiovascular applications. The company’s EUROPA® Posterior Cervical System has received FDA Breakthrough Device Designation. Their technology aims to provide safer, more durable implants with less invasive surgeries and improved patient outcomes through an integrated care continuum

Therapeutic areas: CardiovascularRheumatologyNeurology
Modalities: DeviceImplant
Industry: Implantable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed in available sources.

Beyond the preview

Go deeper on MiRus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MiRus.

Explore the full profile